Peter Salzmann, Chief Executive Officer at Immunovant, Inc. (IMVT), sold 202,678 shares at $21.73 ($4.4M) on 2023-08-07, disclosed to the SEC on 2023-08-08.
Open-market sale of $4.4M IMVT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.73 | 101,339 | $2.2M | 50.0% |
| 2 | $21.73 | 101,339 | $2.2M | 50.0% |
| Total | $21.73 avg | 202,678 | $4.4M | 100% |
| Filing → |
| IMVT | SELL | 2025-02-21 | $644K | — | Filing → |
| IMVT | SELL | 2025-01-17 | $408K | — | Filing → |
| IMVT | SELL | 2025-01-10 | $246K | — | Filing → |